Factors |
| N or median | (% or range) |
Gender | Male:Female | 45:15 |
|
Age (year) |
| 65.0 | (46 - 80) |
Tumor location | Upper:Middle:Lower | 9:36:15 |
|
ASA Score | ASA1:ASA2:ASA3 | 4:37:19 |
|
Neoadjuvant chemotherapy | Present:Absent | 38:22 |
|
Operative procedure (Thoracic) | Thoracoscopy Convert to thoracotomy | 59 1 | 98.3% 1.7% |
Operative procedure (Abdominal) | Laparoscopy Laparotomy | 56 4 | 93.3% 6.7% |
Extent of lymph node dissection | 3 field:2 field | 15:45 |
|
Operation time (min) | Total | 443 | (240 - 874) |
| Thoracic | 174 | (97 - 352) |
Blood loss (ml) | Total | 220 | (20 - 1575) |
| Thoracic | 95 | (10 - 520) |
Number of harvested lymph node |
| 37 | (11 - 101) |
Type of tumor | SCC:AD | 59:1 |
|
Depth of tumor invasion | pT1a:pT1b:pT2:pT3:pT4 | 2:14:12:30:2 |
|
Lymph node metastasis | pN0:pN+ | 28:32 |
|
Pathological stage | I:II:III:IV | 9:22:20:9 |
|
Lymphatic invasion | Present:Absent | 28:32 |
|
Venous invasion | Present:Absent | 35:25 |
|
Postoperative complications | Anastomotic leakage Pneumonia | 5 4 | (8.3%) (6.7%) |
| Conduit necrosis | 2 | (3.3%) |
| Chylothorax | 2 | (3.3%) |
| Bleeding | 1 | (1.7%) |